Great feedback on @Janetbirdope presentation. #RNL2022 “thank you so much Dr. Pope. wish you had more time because the presentation was so applicable to clinical practice” We are so glad you enjoyed!

ACPA is a strong predictor for RA development. any ACPA : 30% developed RA within 3 years. High titer ACPA: 50% developed RA with 3 years. Finally ACPA Titer Matters?! @karen_kc123 @RheumNow #RNL2022 https://t.co/blbVovf1KZ

Healthy behaviors (moderate EtOH, healthy body weight, no smoking, healthy diet, physical activity) associated with lower RA risk "Chronic systemic inflammation fans the flames of brewing RA" @RheumNow #RNL2022 https://t.co/gAerZaAcso

Family history risk includes genetic and shared environmental factors @RheumNow #RNL2022 https://t.co/3J4nisbSX1

ACPA prior to RA diagnosis. Notice epitope spreading proceeding diagnosis!! @karen_kc123 @RheumNow #RNL2022 https://t.co/glgrOdVyyJ

Completed Early RA prevention trials using agents like steroids, RTX, atorvastatin, abatacept No sig difference in steroids, atorvastatin RTX delayed onset but no overall diff Abatacept decreased RA progression at 1.5 years @RheumNow #RNL2022 https://t.co/v7WxI2P7r5

Top Influencers of #RNL2022: @RheumNow @uptoTate @Janetbirdope @NoufAhmedAlham2 @doctorRBC @hausmannMD More 📊 https://t.co/5tIzMLfqrh

• #RNL2022 - RheumNow Live - Social Media Analytics and Transcripts

@Janetbirdope on drug cycling in #RA. What’s beyond TNFi failure? No golden rule, but: 👉🏻 switching to non-TNF can be superior than staying with the TNFi class 👉🏻 response to other bDMARs maybe blunted in non-TNFi naive 👉🏻 JAKi can be a good choice for some @RheumNow #RNL2022 https://t.co/25MiiFh2CK

How NOT to get rheumatoid arthritis. Excellent tips by @karen_kc123 #RNL2022 #rheumatoidarthritis https://t.co/brLeWzioQD

Patients often ask me what they can do on their part to help their disease... this is it! @karen_kc123 reviews the modifable risks in RA. @rheumnow #RNL2022 @CreakyJoints https://t.co/FM0BtNX6eb

#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR

Dr. Elena Myasoedova on Multimorbidities and RA Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts @RheumNow #RNL2022 https://t.co/N6VPdU6wzV

Cool idea 💡 for #treatment of #multimorbidity in #rheumatoid arthritis from an interactive web platform #RNL2022 ⁦@RheumNow⁩ https://t.co/QlTWCV8s9F

Role of cytokines in pain ?! Notice CNS activity disappeared immediately before TJC/SJC improvement!! @Tuhina_Neogi @RheumNow #RNL2022 https://t.co/TXKZwepBTF

@Janetbirdope on drug cycling vs. switching in RA Interesting data showing switching to non-TNFi superior to cycling in TNFi-incomplete responders Most bDMARDs and JAKi have blunted response post-TNFi @RheumNow #RNL2022 https://t.co/Lb3wvHZdzN